171 related articles for article (PubMed ID: 16861717)
1. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
[TBL] [Abstract][Full Text] [Related]
2. Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
Eur J Public Health; 2007 Apr; 17(2):193-8. PubMed ID: 16798782
[TBL] [Abstract][Full Text] [Related]
3. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
Critchley J; Liu J; Zhao D; Wei W; Capewell S
Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
[TBL] [Abstract][Full Text] [Related]
5. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
[TBL] [Abstract][Full Text] [Related]
6. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.
Björck L; Capewell S; Bennett K; Lappas G; Rosengren A
J Intern Med; 2011 Apr; 269(4):452-67. PubMed ID: 21205025
[TBL] [Abstract][Full Text] [Related]
7. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
Bots ML; Grobbee DE
J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
[TBL] [Abstract][Full Text] [Related]
8. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
[TBL] [Abstract][Full Text] [Related]
9. Increasing the impact of cardiological treatments. How best to reduce deaths.
Capewell S; Pell JP; Morrison C; McMurray J
Eur Heart J; 1999 Oct; 20(19):1386-92. PubMed ID: 10487799
[TBL] [Abstract][Full Text] [Related]
10. Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006.
Kabir Z; Perry IJ; Critchley J; O'Flaherty M; Capewell S; Bennett K
Int J Cardiol; 2013 Oct; 168(3):2462-7. PubMed ID: 23541608
[TBL] [Abstract][Full Text] [Related]
11. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
[TBL] [Abstract][Full Text] [Related]
12. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
13. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
[TBL] [Abstract][Full Text] [Related]
14. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
[TBL] [Abstract][Full Text] [Related]
15. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.
Bennett K; Kabir Z; Unal B; Shelley E; Critchley J; Perry I; Feely J; Capewell S
J Epidemiol Community Health; 2006 Apr; 60(4):322-7. PubMed ID: 16537349
[TBL] [Abstract][Full Text] [Related]
16. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
[TBL] [Abstract][Full Text] [Related]
17. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
18. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
[TBL] [Abstract][Full Text] [Related]
19. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.
Laatikainen T; Critchley J; Vartiainen E; Salomaa V; Ketonen M; Capewell S
Am J Epidemiol; 2005 Oct; 162(8):764-73. PubMed ID: 16150890
[TBL] [Abstract][Full Text] [Related]
20. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
Unal B; Critchley JA; Capewell S
BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
